What is the most important diagnostic feature for beta thalassemia trait?
Which type(s) of hemophilia is/are X-linked?
With regards to hereditary spherocytosis, which of the following is false?
In which subtype of Hodgkin's disease are popcorn cells predominantly found?
Blood is stored at what temperature in blood bank?
What is the defect in Glanzmann's thrombasthenia?
In a blood typing test, no agglutination is observed with anti-A and anti-B antisera, but agglutination is observed with anti-D (Rh) antisera. What is the blood type?
Bernard–Soulier syndrome is caused by a deficiency of which glycoprotein complex?
Which disease is associated with the CD59 marker?
In which type of Hodgkin's lymphoma are classical Reed-Sternberg cells most characteristically observed?
Explanation: ***Raised HbA2*** - In beta thalassemia trait, the most significant diagnostic feature is an **increased level of HbA2** (>3.5%), which helps differentiate it from other types of anemias [1]. - This is due to a compensatory mechanism as the body attempts to produce more **alpha globin chains** in response to decreased beta globin production. *Reduced MCV* - While **reduced mean corpuscular volume (MCV)** can indicate microcytic anemia, it is not specific enough for beta thalassemia trait as it can appear in other conditions. - MCV can vary in individuals, making it less reliable as a **diagnostic feature** compared to HbA2 levels. *Raised HbF* - An increase in **hemoglobin F (HbF)** is more characteristic of beta thalassemia major rather than the trait; levels in the trait do not typically rise significantly. - This feature can also be elevated in other conditions, thus not serving as a definitive marker for the trait. *Reduced MCH* - A **decreased mean corpuscular hemoglobin (MCH)** is indicative of microcytic anemia but lacks specificity for beta thalassemia trait alone. - Similar to MCV, it can occur in various types of anemia and does not pinpoint the diagnosis effectively. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 649-650.
Explanation: ***Both A & B*** - Both **Hemophilia A** and **Hemophilia B** are **X-linked recessive** disorders [1][2] caused by deficiency of specific clotting factors (Factor VIII for A and Factor IX for B). - They are inherited through **carrier females**, affecting predominantly males, showcasing their X-linked transmission [1]. *Hemophilia A* - It is indeed an **X-linked recessive** disorder [2] but does not encompass all types of hemophilia. - It results from a deficiency in **Factor VIII** [2], leading to bleeding disorders, yet is just one form of hemophilia. *Hemophilia C* - This form is **autosomal recessive** and not linked to the X chromosome, primarily affecting both genders equally. - It involves a deficiency of **Factor XI**, distinguishing it from the X-linked nature of A and B. *Hemophilia B* - Like Hemophilia A, it is X-linked but by itself does not account for all hemophilias. - It results from a deficiency in **Factor IX**, yet the question about X-linkage applies to both A and B together. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 151. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 670-671.
Explanation: ***Aplastic crises are common*** - Aplastic crises occur in cases of **hereditary spherocytosis** due to parvovirus B19 infections, leading to **acute cessation of erythropoiesis** [1][3]. - They are characterized by a **sudden drop in hemoglobin levels**, which is not a common feature of hereditary spherocytosis itself, hence the misconception [1]. *Usually has autosomal dominant inheritance* - Hereditary spherocytosis is primarily inherited in an **autosomal dominant pattern**, where one copy of the mutated gene is sufficient to cause the disease. - However, it can also present in an **autosomal recessive** form, making this statement misleading. *Red blood cells are destroyed in the spleen* - This statement is actually **true**; hereditary spherocytosis leads to the **destruction of abnormally shaped red blood cells** in the spleen due to their rigid membrane structure [2][3]. - The condition is characterized by **hemolytic anemia** resulting from splenic sequestration [3]. *Caused by mutations in genes for proteins such as spectrin, ankrin or band 3* - This is a **correct statement**, as hereditary spherocytosis results from mutations in **membrane proteins** that result in loss of elasticity and stability of the red blood cell membrane [2]. - The mutations commonly involve **spectrin, ankyrin, and band 3 proteins**, leading to the pathophysiology seen in this condition [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 641-642. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 640-641. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 597-598.
Explanation: ***Lymphocyte predominant*** - Popcorn cells, or **"L&H" (Lymphocytic and Histiocytic) cells**, are characteristic of lymphocyte predominant Hodgkin's disease, indicating a **rich lymphocytic background** [1]. - This subtype is more commonly seen in younger patients and is associated with a better prognosis relative to other types of Hodgkin's lymphoma [1]. *Mixed cellularity* - This subtype is characterized by a **varied cellular composition** including numerous Reed-Sternberg cells but does not specifically feature popcorn cells [2]. - It tends to have a higher number of **eosinophils** and **plasma cells** rather than lymphocytes predominating [2]. *Lymphocyte depletion* - Lymphocyte depletion is marked by a **deficient lymphocytic component** and an abundance of Reed-Sternberg cells, lacking the characteristic popcorn cells. - This variant is often more aggressive and typically has a poorer prognosis. *Nodular sclerosis* - Nodular sclerosis is recognized by the presence of **collagen bands** separating lymphoid nodules and also does not include popcorn cells. - This form is the most common variant of Hodgkin's lymphoma and often presents with **mediastinal masses**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 618. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 616-618.
Explanation: ***1 to 6 degrees Celsius*** - This temperature range is critical for maintaining the **viability of red blood cells** and slowing down metabolic processes, ensuring the blood is safe for transfusion. - At this temperature, the growth of most **pathogenic bacteria** is inhibited, and the degradation of blood components is minimized. *-2 to -4 degrees Celsius* - Temperatures below 0°C would cause **ice crystal formation** within the red blood cells, leading to hemolysis and making the blood unsuitable for transfusion. - This range is typically used for the **long-term storage of frozen plasma** or cryoprecipitate after special processing, not whole blood or red blood cell units. *-2 to 0 degrees Celsius* - This temperature range is incorrect for storing whole blood or packed red blood cells as it is still likely to cause **freezing and cellular damage**. - While close to freezing, even slight freezing can result in **hemolysis** and render the blood product unusable. *6 to 12 degrees Celsius* - Temperatures above 6°C significantly increase the **metabolic activity of red blood cells** and the risk of **bacterial growth**. - This range would lead to a more rapid decline in the viability and safety of the stored blood, reducing its shelf life considerably.
Explanation: ***Gp1Ib-IlIa*** - Glanzmann's thrombasthenia is characterized by a defect in the **Gp1b-IlIa complex**, which is essential for platelet aggregation. - Patients with this condition exhibit **prolonged bleeding time** and poor clot formation due to ineffective platelet-fibrinogen binding. *GpIIIa-I lb* - This option refers to a component of the GpIIb-IIIa complex, which is primarily involved in **platelet aggregation** and is not the defect in Glanzmann's thrombasthenia. - Defects in GpIIb-IIIa lead to conditions such as **Glanzmann's thrombasthenia** [1], but specifically, the Gp1b-IlIa complex is implicated. *Gpfilb-I la* - This designation does not correspond correctly to either a known receptor complex related to platelet function or to Glanzmann's thrombasthenia. - Mislabeling of the glanzmann's complex results in confusion as it does not specify the **correct interaction involved in platelet aggregation**. *GpIla-Illb* - This combination refers to components that are not involved in Glanzmann's thrombasthenia, which specifically involves the **Gp1b-IlIa interaction**. - GpIla-Illb complex is part of the **integrin family**, but its defect does not lead to the bleeding problems seen in Glanzmann's thrombasthenia [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 668-669.
Explanation: ***O+ve*** - No agglutination with **anti-A** and **anti-B antisera** indicates the absence of A and B antigens, characteristic of **blood group O**. - Agglutination with **anti-D (Rh) antisera** signifies the presence of the **Rh antigen**, thereby indicating a positive (+) blood type. *O-ve* - While no agglutination with anti-A and anti-B points to **blood group O**, no agglutination with **anti-D** would be expected for an Rh-negative type. - The observed agglutination with **anti-D** contradicts an Rh-negative classification. *A+ve* - Agglutination with **anti-A antisera** would be expected for an A blood type, which is not observed in this scenario. - While agglutination with **anti-D** is consistent with 'positive', the absence of agglutination with **anti-A** rules out 'A' blood group. *B-ve* - Agglutination with **anti-B antisera** would be expected for a B blood type, which is not observed in this scenario. - The agglutination with **anti-D** contradicts an Rh-negative classification, making **B-ve** incorrect.
Explanation: ***Gp 1b*** - Bernard–Soulier syndrome is primarily caused by a deficiency in **Gp1b**, which is crucial for platelet adhesion to the von Willebrand factor (vWF) [1]. - This results in **thrombocytopenia** and large platelets, which are characteristic features of the syndrome. *Gp 2b/3a* - Gp2b/3a is associated with **Glanzmann thrombasthenia**, not Bernard–Soulier syndrome [1]. - This receptor is essential for platelet aggregation and binds fibrinogen, contributing to a different bleeding disorder. *TNF* - Tumor Necrosis Factor (TNF) is a cytokine involved in systemic inflammation and does not directly relate to platelet function or deficiencies. - Deficiency of TNF is unrelated to bleeding disorders like Bernard–Soulier syndrome. *vWf* - von Willebrand factor (vWf) deficiency is associated with **von Willebrand disease**, which presents differently than Bernard–Soulier syndrome. - vWf is essential for the aggregation of platelets but is not the deficient factor in this syndrome. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 668-669.
Explanation: ***PNH*** - The **CD59 marker** is associated with **Paroxysmal Nocturnal Hemoglobinuria (PNH)**, a condition characterized by the loss of glycosylphosphatidylinositol (GPI) anchored proteins [1]. - It protects red blood cells from **complement-mediated lysis**, and its absence leads to hemolysis and thrombosis in patients with PNH [1,4]. *PTEN* - The **PTEN gene** is a tumor suppressor associated with various cancers and is not related to CD59. - It is primarily involved in the **regulation of the Akt signaling pathway**, not in complement regulation. *BRR* - **BRR (Birt-Hogg-Dubé syndrome)** is linked to folliculin and does not involve CD59. - This genetic condition is characterized by **skin tumors** and renal tumors, unrelated to the complement system. *Cowden syndrome* - **Cowden syndrome** is associated with mutations in the PTEN gene, relating to **hamartomas** and breast cancer risk, not CD59. - It affects multiple systems but does not involve **complement regulatory proteins** like CD59. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 650-651. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 601-602.
Explanation: ***Lymphocyte predominance*** - The **Hodgkin's lymphoma (HL) lymphocyte predominance** variant characteristically displays a predominance of lymphocytes in the cellular makeup [1]. - This subtype is often associated with a better prognosis and fewer symptoms than other types of HL [1]. *Lymphocyte depleted* - This subtype features a significant decrease in lymphocytes, leading to a **higher proportion of Reed-Sternberg cells** [3]. - It typically presents with a more aggressive clinical course, which contrasts with lymphocyte predominance [3]. *Mixed cellularity hodgkin* - Mixed cellularity shows a variety of cell types, including a significant number of **Reed-Sternberg cells**, but does not demonstrate **lymphocyte predominance** [2]. - This subtype is generally found in older patients and associated with advanced disease, unlike lymphocyte predominance [2]. *Nodular sclerosis* - Nodular sclerosis subtype is characterized by **collagen bands** and a particular architecture that is distinct from lymphocyte predominance [2]. - It primarily affects younger patients and can often involve mediastinal lymph nodes; however, it does not have the features of lymphocyte predominance [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 618. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 616-618. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 559-560.
Anemias: Classification and Approach
Practice Questions
Hemolytic Anemias
Practice Questions
Myeloproliferative Neoplasms
Practice Questions
Myelodysplastic Syndromes
Practice Questions
Acute Leukemias
Practice Questions
Chronic Leukemias
Practice Questions
Lymphomas and Lymphoid Neoplasms
Practice Questions
Plasma Cell Disorders
Practice Questions
Bleeding Disorders
Practice Questions
Thrombotic Disorders
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free